This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2003;64(4):479-80.

doi: 10.1159/000070313.

Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study

Emanuela Rossi, Francesco Perrone, Vincenzo Labonia, Gabriella Landi, Francesco Nuzzo, Gerardo Amabile, Cesare Gridelli, Massimo Di Maio, Giuseppe D'Aiuto, Andrea de Matteis

PMID: 12759551
DOI: 10.1159/000070313

Clinical Trial

Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study

Emanuela Rossi et al. Oncology. 2003.

. 2003;64(4):479-80.

doi: 10.1159/000070313.

Authors

Emanuela Rossi, Francesco Perrone, Vincenzo Labonia, Gabriella Landi, Francesco Nuzzo, Gerardo Amabile, Cesare Gridelli, Massimo Di Maio, Giuseppe D'Aiuto, Andrea de Matteis

PMID: 12759551
DOI: 10.1159/000070313

No abstract available

PubMed Disclaimer

Similar articles

Weekly docetaxel and gemcitabine following docetaxel plus epirubicin or vinorelbine as first-line treatment of metastatic breast cancer: results of a multicenter phase II study.
Riccardi A, Brugnatelli S, Danova M, Giordano M, Pugliese P, Luchena G, Grasso D, Trotti G, Bertè R, Pansini G, Tinelli C. Riccardi A, et al. Tumori. 2006 Jan-Feb;92(1):6-12. doi: 10.1177/030089160609200102. Tumori. 2006. PMID: 16683377 Clinical Trial.
Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
O'Shaughnessy J. O'Shaughnessy J. Oncology (Williston Park). 2003 Dec;17(12 Suppl 14):15-21. Oncology (Williston Park). 2003. PMID: 14768400 Review.
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.
Martín M, Ruiz A, Muñoz M, Balil A, García-Mata J, Calvo L, Carrasco E, Mahillo E, Casado A, García-Saenz JA, Escudero MJ, Guillem V, Jara C, Ribelles N, Salas F, Soto C, Morales-Vasquez F, Rodríguez CA, Adrover E, Mel JR; Spanish Breast Cancer Research Group (GEICAM) trial. Martín M, et al. Lancet Oncol. 2007 Mar;8(3):219-25. doi: 10.1016/S1470-2045(07)70041-4. Lancet Oncol. 2007. PMID: 17329192 Clinical Trial.
Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.
Halim A, Wahba H. Halim A, et al. Med Oncol. 2012 Jun;29(2):454-8. doi: 10.1007/s12032-011-9868-1. Epub 2011 Feb 25. Med Oncol. 2012. PMID: 21350875 Clinical Trial.
Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer.
Hortobagyi GN. Hortobagyi GN. Clin Breast Cancer. 2002 May;3 Suppl 1:34-8. doi: 10.3816/cbc.2002.s.008. Clin Breast Cancer. 2002. PMID: 12057044 Review.

See all similar articles

Cited by

Gemcitabine and vinorelbine combination chemotherapy in anthracycline- and taxane-pretreated advanced breast cancer.
Kim HJ, Kim JS, Seo MD, Oh SY, Oh DY, Kim JH, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ. Kim HJ, et al. Cancer Res Treat. 2008 Jun;40(2):81-6. doi: 10.4143/crt.2008.40.2.81. Epub 2008 Jun 30. Cancer Res Treat. 2008. PMID: 19688053 Free PMC article.
Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study.
Schmid P, Heilmann V, Schulz CO, Dieing A, Lehenbauer-Dehm S, Jehn C, Sezer O, Possinger K, Flath B. Schmid P, et al. J Cancer Res Clin Oncol. 2005 Sep;131(9):568-74. doi: 10.1007/s00432-005-0675-y. Epub 2005 Oct 20. J Cancer Res Clin Oncol. 2005. PMID: 16044345 Free PMC article. Clinical Trial.
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain.
Colomer R, Llombart-Cussac A, Tusquets I, Rifà J, Mayordomo JI, Ojeda B, Ciruelos E, Hornedo J, Vicente D, Cortés-Funes H. Colomer R, et al. Clin Transl Oncol. 2006 Dec;8(12):896-902. doi: 10.1007/s12094-006-0153-2. Clin Transl Oncol. 2006. PMID: 17169763 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland
Medical
- MedlinePlus Health Information